185 related articles for article (PubMed ID: 16503367)
1. Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery.
Paccez JD; Luiz WB; Sbrogio-Almeida ME; Ferreira RC; Schumann W; Ferreira LC
Vaccine; 2006 Apr; 24(15):2935-43. PubMed ID: 16503367
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles.
Paccez JD; Nguyen HD; Luiz WB; Ferreira RC; Sbrogio-Almeida ME; Schuman W; Ferreira LC
Vaccine; 2007 Jun; 25(24):4671-80. PubMed ID: 17498854
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis.
Hoang TH; Hong HA; Clark GC; Titball RW; Cutting SM
Infect Immun; 2008 Nov; 76(11):5257-65. PubMed ID: 18779344
[TBL] [Abstract][Full Text] [Related]
4. Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit.
Luiz WB; Cavalcante RC; Paccez JD; Souza RD; Sbrogio-Almeida ME; Ferreira RC; Ferreira LC
Vaccine; 2008 Jul; 26(32):3998-4005. PubMed ID: 18597902
[TBL] [Abstract][Full Text] [Related]
5. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
6. Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli.
Ma Y; Luo Y; Huang X; Song F; Liu G
Microbiology (Reading); 2012 Feb; 158(Pt 2):498-504. PubMed ID: 22053005
[TBL] [Abstract][Full Text] [Related]
7. Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein.
Wu CM; Chung TC
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):354-65. PubMed ID: 17651125
[TBL] [Abstract][Full Text] [Related]
8. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
[TBL] [Abstract][Full Text] [Related]
9. Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.
Liu W; Li X; Bao J; Guan W; Zhao Z; Yuan C; Tang J; Shi D
Appl Microbiol Biotechnol; 2015 May; 99(9):4005-18. PubMed ID: 25567512
[TBL] [Abstract][Full Text] [Related]
10. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
12. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.
Kim TG; Kim BG; Kim MY; Choi JK; Jung ES; Yang MS
Mol Biotechnol; 2010 Jan; 44(1):14-21. PubMed ID: 19657748
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis, germination and killing of Bacillus subtilis spores presenting heterologous antigens in human macrophages.
Ceragioli M; Cangiano G; Esin S; Ghelardi E; Ricca E; Senesi S
Microbiology (Reading); 2009 Feb; 155(Pt 2):338-346. PubMed ID: 19202083
[TBL] [Abstract][Full Text] [Related]
14. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores.
Zhou Z; Gong S; Li XM; Yang Y; Guan R; Zhou S; Yao S; Xie Y; Ou Z; Zhao J; Liu Z
J Med Microbiol; 2015 Jan; 64(Pt 1):104-110. PubMed ID: 25355934
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli.
Alerasol M; Mousavi Gargari SL; Nazarian S; Bagheri S
Iran Biomed J; 2014; 18(4):212-218. PubMed ID: 25326019
[TBL] [Abstract][Full Text] [Related]
16. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.
Mason HS; Haq TA; Clements JD; Arntzen CJ
Vaccine; 1998 Aug; 16(13):1336-43. PubMed ID: 9682399
[TBL] [Abstract][Full Text] [Related]
17. Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.
Jawale CV; Lee JH
Clin Vaccine Immunol; 2014 Jun; 21(6):799-807. PubMed ID: 24671556
[TBL] [Abstract][Full Text] [Related]
18. An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo.
Baliban SM; Michael A; Shammassian B; Mudakha S; Khan AS; Cocklin S; Zentner I; Latimer BP; Bouillaut L; Hunter M; Marx P; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Infect Immun; 2014 Oct; 82(10):4080-91. PubMed ID: 25024365
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Bacillus subtilis spores for the delivery of Mycobacterium tuberculosis Ag85B-CFP10 secretory antigens.
Das K; Thomas T; Garnica O; Dhandayuthapani S
Tuberculosis (Edinb); 2016 Dec; 101S():S18-S27. PubMed ID: 27727129
[TBL] [Abstract][Full Text] [Related]
20. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.
Moravec T; Schmidt MA; Herman EM; Woodford-Thomas T
Vaccine; 2007 Feb; 25(9):1647-57. PubMed ID: 17188785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
